Dear Members,
Your Directors are pleased to submit the 41st Annual Report
on the Business and Operations of the Company along with its Audited Financial Statements
for the Financial Year (FY) ended 31st March, 2026.
Financial Highlights
The financial performance of the Company for the Financial Year ended
31st March, 2026 is summarised below:
| Particulars |
FY 2025-26 |
Standalone FY 2024-25 |
Consolidated FY 2024-25 |
| Revenue From Operations |
2019.79 |
2035.15 |
2035.15 |
| Other Income |
43.01 |
36.10 |
36.10 |
| Total Revenue |
2062.80 |
2071.26 |
2071.26 |
| EBIDTA |
446.49 |
452.71 |
452.71 |
| Depreciation |
64.22 |
55.46 |
55.46 |
| Finance Cost |
3.71 |
5.11 |
5.11 |
| Profit before Tax |
378.56 |
392.14 |
392.14 |
| Provision for Taxation |
91.33 |
95.18 |
95.18 |
| Profit after Tax (PAT) |
287.23 |
296.96 |
296.96 |
| Other Comprehensive Income |
0.94 |
1.41 |
1.41 |
| Total Comprehensive Income for the Period |
288.17 |
298.37 |
298.37 |
| Balance of Profit brought forward from previous years |
1391.76 |
1244.92 |
1244.91 |
| Total |
1679.94 |
1543.29 |
1543.28 |
| Appropriations |
|
|
|
| Less: Amount utilized for Buyback of Equity Shares |
- |
(99.90) |
(99.90) |
| Less: Amount Transferred to Capital Redemption Reserve on
Buyback of Equity Shares |
- |
(0.10) |
(0.10) |
| Less: Tax Paid on Buyback |
- |
(23.27) |
(23.27) |
| Less: Dividend on Equity Shares |
(9.02) |
(27.35) |
(27.35) |
| Leases (Ind AS 116) transition effect |
- |
NIL |
NIL |
| Balance Profit carried forward to Balance Sheet |
1670.92 |
1392.67 |
1392.66 |
Note: The wholly owned subsidiary of the Company, Dhanuka Chemicals
Private Limited (DCPL) made a voluntary application with the jurisdictional Registrar of
Companies ("ROC"), to strike off its name from the ROC. Consequently, the name
of DCPL has been struck off from the record of ROC w.e.f. 16th July, 2024 and
it ceased to be the Wholly Owned Subsidiary of the Company from the said date.
As on the date of this Report, the Company does not have any
subsidiary. Accordingly, the requirement to prepare consolidated financial statements is
not applicable to the Company for the Financial Year under review.
Consolidated Financial Statements
During the period under review, the Company does not have any
subsidiary, associate or joint venture company and hence the Company is not required to
Consolidate its Financial Statements.
Business Operations
During the period under review, the broader operating environment for
the agrochemical industry remained challenging. The sector continued to face pressure from
erratic weather patterns, uneven crop economics, and weak channel liquidity in certain
regions. In addition, persistent global volatility in commodity markets and supply chain
dynamics further accentuated in March 2026 due to geopolitical developments in the Gulf
region impacted overall industry sentiment.
Climate variability is increasingly emerging as a structural factor for
Indian agriculture. Unseasonal rainfall, temperature fluctuations, and shifting monsoon
patterns continue to influence sowing behaviour, crop productivity, input demand, and
overall farmer sentiment.
This year, the Rabi season was additionally affected by unfavourable
climatic conditions in certain key regions. While near-term demand visibility remains
contingent upon monsoon progression and reservoir levels, the Company remains constructive
on the medium to long-term structural growth prospects of Indian agriculture and crop
production.
Your Company, Dhanuka Agritech Limited, is among India's leading
agrochemical companies, with a long-standing commitment to advancing Indian agriculture
through technology-driven crop solutions. Over the years, the Company has built a strong
pan-India presence supported by deep farmer engagement, a differentiated product
portfolio, and a robust distribution network.
The Company has reached over 10 million farmers across India through
approximately 6,500 distributors and more than 80,000 retailers. Supported by four
manufacturing facilities and 41 warehouses, the Company continues to strengthen its
ability to efficiently deliver products across key agricultural markets.
A key differentiator for the Company has been its consistent focus on
introducing innovative and globally relevant chemistries in the Indian market. Strategic
partnerships with ten leading multinational agrochemical innovators from Japan, Europe,
and the United States continue to provide access to advanced technologies and
differentiated solutions for Indian farmers.Your Company has two R&D centers,
supported by NABL-accredited laboratories and a strong regulatory and product development
team, remain focused on product registration, formulation development, and strengthening
Company's future growth pipeline.
Dhanuka has a healthy Net worth of ^1681.88 Crores as on 31st
March, 2026.
During the Financial Year 2025-26, the Company received multiple
product registrations from the Central Insecticides Board & Registration Committee
(CIB&RC), Government of India, under various regulatory categories, further
strengthening its product portfolio and market presence. The Company secured two
registrations under Section 9(3), namely Ipflufenoquin 20% SC (FIM) for rice and
Sulfoxaflor 50% WG (FI) for cotton. Additionally, nine registrations were obtained under
Section 9(4) (FIM), comprising herbicides such as Metolachlor 50% EC, Pendimethalin 30% +
Imazethapyr 2% EC, Sulfentrazone 39.6% SC, Sulfentrazone 19% + Pretilachlor 28.5% SE, and
Sulfentrazone 28% + Clomazone 30% WP; and insecticides including Acephate
50% + Bifenthrin 10% WDG, Acetamiprid 25% + Bifenthrin 25% WG,
Bifenthrin 8.8% CS, and Diafenthiuron 47% + Bifenthrin 9.4% SC, catering to key crops such
as soybean, wheat, cotton, rice, sugarcane, and chilli.
Further, the Company obtained two technical registrations under Section
9(4) (TI), being Zoxamide Technical 97% and Glyphosate Technical 95% (Import Only). These
approvals reinforce the Company's continued focus on expanding its product offerings with
advanced and effective crop protection solutions.
During the year under review, the Company also strengthened its export
portfolio by securing multiple registrations from the Central Insecticides Board &
Registration Committee (CIB&RC), Faridabad, Haryana exclusively for export markets.
The Company obtained six registrations under Section 9(3) (FIM) for export purposes,
including formulations such as Iprovalicarb 8.4% + Copper Oxychloride 68.2% WG, Dimethoate
40% EC, Acetamiprid 2.7% EC, Triadimenol 150 g/L FS, and Imidacloprid 175 g/L +
Triadimenol 250 g/L SC, catering primarily to fungicidal and insecticidal applications.
Further, the Company secured twelve registrations under Section 9(3)
(TIM) for export only, covering a range of technical grade insecticides and fungicides.
These include insecticide technicals such as Bifenthrin, Thiacloprid, Clothianidin,
Cyantraniliprole, and Cyfluthrin; and fungicide technicals including Iprovalicarb,
Thiophanate Methyl, Propineb (80% and 85%), Picoxystrobin (93% and 97%), Epoxiconazole,
Dimethomorph, and Triadimenol.
These registrations reinforce the Company's growing international
footprint and its continued focus on expanding its presence in global markets through a
diversified and competitive product portfolio.
In line with the Company's strategic objective to expand its global
footprint, the Board has also approved the incorporation of two wholly owned subsidiaries
in Brazil and a European country. This will facilitate the Company's international
operations, particularly in relation to transfer of brand registrations and expansion of
product availability in these markets.
Dividend
The Board of Directors has recommended a Final Dividend of 100% i.e.
Rs. 2/- per equity share having a face value of Rs. 2/- each for the Financial Year
2025-26. The said Final Dividend is subject to the approval of the Members at the ensuing
Annual General Meeting (AGM). The Final Dividend shall be paid on or before 2nd September,
2026 to those shareholders whose names appear in the Register of Beneficial Owners/
Members as on the record date fixed by the Company.
Dividend Distribution Policy
Pursuant to Regulation 43A of the Securities and Exchange Board of
India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing
Regulations'), the Board of Directors of the Company have a Dividend Distribution Policy
in place which aims to maintain a balance between profit retention and a fair, sustainable
and consistent distribution of profits among its Members. The said Policy is available on
the website of the Company under the 'Investors' section at https://www.dhanuka.com/policies
The said policy is annexed to this Report as Annexure-"A".
Transfer to General Reserve
This year no amount has been transferred to the General Reserve.
Equity Share Capital
The paid-up Equity Share Capital as on March 31, 2026 was ^ 9.02 crore.
During the year under review, the Company has not issued any shares.
Material changes and commitments affecting the financial position of
the Company between the end of the Financial Year and the date of this Report
There were no material changes and commitments affecting the financial
position of the Company between the end of the Financial Year and the date of this Report
except that the board of directors of the Company at their meeting held on 19th
May, 2026 inter-alia approved the following proposal(s)-
- approval for buyback of up to 5,00,000 (Five Lakh) equity shares of
the Company for an aggregate amount not exceeding ^70 crore, at a maximum buyback price of
^1,400 per equity share;
- approved the "Dhanuka Employee Stock Option Plan 2026" and
the "Dhanuka Employee Stock Appreciation Rights 2026".
Company's Performance
The revenue from operations for FY 2025-26 was ^ 2,019.79 crore, lower
by (0.75%) over the previous year's revenue from operations of ^ 2,035.15 Crore. Profit
before exceptional items and tax for FY 2025-26 was ^ 378.56 crore, lower by (3.46%) from
^ 392.14 crore in FY 202425. The profit for the year in FY 2025-26 was ^ 287.23 crore
lower by (3.28%) over the profit of ^ 296.96 crore in FY 2024-25.
Credit Ratings
During the year under review, there were no changes in the credit
ratings of the Company. As on March 31, 2026, CARE
Ratings Limited has reaffirmed the ratings of the Company's bank
facilities as 'CARE AA; Stable' for long-term bank facilities and 'CARE A1+' for
short-term bank facilities.
Particulars of Inter Corporate Loans, Guarantees or Investments
During the year under review, the Company has not made any investment.
Further, the Company has not given any loan or corporate guarantee or provided any
security during the year.
Details of loans, guarantees and investments covered under the
provisions of Section 186 of the Companies Act 2013 ("Act") are given in the
notes to the Financial Statements.
Related Party Transactions
The Company has formulated a Policy on Related Party Transactions in
accordance with the Act and the SEBI Listing Regulations including any amendments thereto
for identifying, reviewing, approving and monitoring of Related Party Transactions
('RPTs') which is available on the Company's website at https://www.dhanuka.com/policies .
All RPTs are presented to the Audit Committee for review and approval.
Prior omnibus approval of the Audit Committee is obtained on periodic basis for the
transactions which are planned / repetitive in nature. A statement giving details of all
RPTs entered pursuant to omnibus approval so granted is placed before the Audit Committee
on a quarterly basis for its review. All the RPTs under Ind AS-24 have been disclosed in
Note No. 40 to the Financial Statements forming part of this Annual Report.
Particulars of contracts or arrangements with Related Parties pursuant
to Section 134(3)(h) of the Act read with rule 8(2) of the Companies (Accounts) Rules,
2014 in Form AOC-2 are given in Annexure "E" forming part of this Report.
During the year under review, the Company has not entered into any
transactions with Related Parties that could be considered material in terms of the
Company's policy on the materiality of Related Party Transactions read with SEBI Listing
Regulations.
In terms of Regulation 23 of the SEBI Listing Regulations, the Company
submits details of RPTs as per the prescribed format to the stock exchanges on a
half-yearly basis.
Transfer of Unpaid/ Unclaimed Dividend and Shares to IEPF
Pursuant to the provisions of Section 124(6) of the Act and the rules
mentioned therein, during the Financial Year under review, the Company has transferred
Final Dividend of ^ 8,25,654 (Rupees Eight Lakh Twenty Five Thousand Six Hundred Fifty
Four only) for the FY 2017-18 to the Investors Education and Protection Fund (IEPF) of the
Central
Government of India. Further the company has not transferred any shares
to Investor Education and Protection Fund Authority (IEPFA) as the seven consecutive years
were not completed.
Further, pursuant to the provisions of section 124 (6) of the Act and
the rules mentioned therin, Final Dividend for the Financial Year 2018-19 and Interim
Dividend for the Financial Year 2019-20 along with 15,505 Equity Shares of the members who
have not claimed their final dividend for the year 2018-19, shall be transferred to
Investor Education and Protection Fund Authority (IEPFA) in due course.
The details of the same is available at the website of the company i.e.
www.dhanuka.com
Subsidiary Companies
During the period under review, the Company doesnot have any
subsidiary. Accordingly, the disclosure of statement containing the salient features of
Financial Statements of the Company's subsidiary as required under Section 129(3) of the
Act in Form No. AOC-1 is not applicable to the Company for FY 2025-26 and hence does not
form part of this Annual Report.
Future Prospects
Dhanuka's Corporate Vision "Transforming India through
Agriculture" signifies a responsive, trustworthy and farmers' friendly organization.
'Dhanuka Kheti Ki Nai Takneek (DKKNT)', is a holistic approach to Integrated Crop
Management for higher yields and in turn higher farmers' income. The Company is remarkably
contributing towards "Transforming India Through Agriculture" by educating
Indian farmers with new and innovative techniques of farming.
The Indian pesticide industry is expected to witness steady demand over
the coming year, supported by healthy reservoir levels, which provide a favourable
backdrop for agricultural activity. Demand is likely to remain closely linked to monsoon
performance, pest and disease incidences, cropping patterns, and overall farm sentiment,
particularly during the Kharif and Rabi seasons.
While current water storage levels provide a reasonable support, the
possibility of localized weather disruptions and climatic anomalies, including El
Nino-related impacts, could influence agricultural activities, crop health, and in turn
impact the pesticide consumption patterns across regions. On the global front, global
agrochemical markets are gradually stabilizing following an extended inventory correction
cycle, although geopolitical tensions in key regions, including the Middle East, continue
to pose risks to supply chains, logistics, and raw material availability. Overall, the
increasing need for crop protection, productivity
enhancement and contingent on weather conditions, global trade
dynamics, and other developments across the agricultural ecosystem likely to support
demand for pesticide consumption this year.
Considering above, this year, the demand for all the Company's products
is expected to be very good. The Company has a strong pipeline of section 9(3) and 9(4)
products. This will drive revenue growth in the coming years. Further, the Company is
working towards engaging with all the participants across the value chain both upstream
and downstream to deliver a strong kharif season and build a solid momentum for the
Financial Year 2026-27.
With four manufacturing units and 41 warehouses across India, we cater
to around 6,500 distributors and 80,000 retailers. Dhanuka has a strong Sales and
Marketing team to promote and develop new products. Over last couple of years we have set
up, 2 research and technology centers to enhance our focus on innovation and research. One
of the centers is focused on applied chemistry and working for establishment of new
products and new formulation development. The second laboratory is focused on innovation
in process technology for generic and late stage patented products.
Product Launch
The following Products have been launched during the Financial Year
2025-26 :
1. Dinkar:
Dinkar (Ipfencarbazone 25% SC) is a new generation cutting-edge
herbicide developed through a strategic collaboration between Dhanuka Agritech Ltd and
Hokko Chemical Industry Co., Ltd Japan. This innovative formulation solves significant
issues that paddy farmers face when controlling resistant weed species.
2. Melody Duo:
Melody Duo is a highly effective fungicide that controls downy mildew
in grapes and early and late blight in potatoes and tomatoes, offering protective,
antisporulant, and eradicative action. It ensures strong protection of young plant parts,
enhances produce quality at harvest, and supports better resistance management through its
synergistic dual active ingredients.
3. Verdour:
Verdour is a sea-based organic biofertilizer that enhances crop vigour,
supports root growth, and improves tolerance to environmental stress. It promotes better
foliage, flowering, fruit set, and yield quality. Suitable for a wide range of crops, it
is applied as a
foliar spray @ 100 g/acre in 150-200 litres of water during key growth
and stress stages, with 2-3 applications per crop cycle.
Directors and Key Managerial Personnel
Directors
Appointment:
The Board of Directors of the Company, based on the recommendations of
the Nomination and Remuneration Committee, approved the appointment of Mr. Sanjiv Goel
(DIN: 03616090) as an Additional Director in Independent capacity for an initial term of
five (5) years with effect from 5th February, 2026 and his appointment as an Independent
Director was subsequently approved by the Shareholders by way of a special resolution
passed through postal ballot on 19th March, 2026.
Cessations:
1. Mr. Siraj Azmat Chaudhary (DIN: 00161853), Independent Director of
the Company, ceased as Director of the Company upon completion of his first term with
effect from the close of business hours on 21st July, 2025 due to increasing
professional commitments and time constraints. There were no other material reasons for
his resignation. The Board places on record its sincere appreciation for the valuable
contributions made by him during his tenure with the Company.
2. Mr. Sachin Kumar Bhartiya, (DIN:02122147), Independent Director of
the Company ceased as Director of the Company upon completion of his second term with
effect from the close of business hours on 8th February, 2026. The Board places
on record its sincere appreciation for the valuable contributions made by him during his
tenure with the Company.
Re-appointments:
In accordance with the provisions of Section 152 of the Act and in
terms of clause 58 of the Article of the Articles of Association of the Company, Mr. Harsh
Dhanuka (DIN: 00199516), and Mr. Ashish Saraf (DIN:07767324) Executive Directors of the
Company, retires by rotation at the ensuing AGM and being eligible, offers themselves for
reappointment.
Key Managerial Personnel ('KMP's)
In terms of the provisions of section 2(51) and 203 of the Act, the
following are the KMP's of the Company as on March 31, 2026:
1. Mr. Mahendra Kumar Dhanuka- Chairman & Executive Director
2. Mr. Rahul Dhanuka, Managing Director
3. Mr. VK Bansal, Chief Financial Officer
4. Mr. Jitin Sadana, Company Secretary & Compliance Officer
During the year under review, there was no change in KMP's.
Declaration by Independent Directors & Familarisation Programme:
The Independent Directors of the Company have given the declarations
confirming that they meet the criteria of independence as laid down under Section 149(6)
of the Act and Regulation 16(1)(b) of the SEBI Listing Regulations. In terms of Regulation
25(8) of the SEBI Listing Regulations, they have further confirmed that they are not aware
of any circumstance or situation, which exists or may be reasonably anticipated, that
could impair or impact their ability to discharge their duties with objective, independent
judgement and without any external influence.
The Board of Directors of the Company has taken on record the
declarations and confirmations submitted by the Independent Directors.
The Independent Directors of the Company have confirmed that they have
enrolled themselves in the Independent Directors' Databank maintained with the Indian
Institute of Corporate Affairs ('IICA') in terms of Section 150 of the Act read with Rule
6 of the Companies (Appointment & Qualification of Directors) Rules, 2014, as amended.
The Independent Directors are compliant with the requirements relating to the online
proficiency self-assessment test conducted by IICA, as applicable.
Further, in the opinion of the Board, Independent Directors of the
Company are persons of high integrity, expertise and experience (including the
proficiency) and thus qualify to be appointed/continued as Independent Directors of the
Company.
The Independent Directors have also confirmed that they have complied
with the Company's Code of Conduct as prescribed in Schedule IV to the Act.
During the year under review, the Non-Executive Directors of the
Company had no pecuniary relationship or transactions with the Company, other than receipt
of sitting fees and reimbursement of expenses, if any incurred by them in connection with
attending meetings of the Board and its Committees.
Details of Familiarisation Programme for the Independent Directors are
available on the website of the Company at https://www.dhanuka.com/familization
Performance Evaluation
In compliance with the requirement of Section 134(3)(p) and Schedule IV
of the Act and Rules framed thereunder and Regulation 17(10) of SEBI Listing Regulations
based on the recommendation received from the Nomination and Remuneration Committee, the
Board of Directors of the Company evaluated and assessed the performance of the Company's
Chairman, Individual Directors, Board as a whole and its Committees on the basis of
parameters set by the Nomination and Remuneration Committee in the form of questionnaire
based on emerging and leading practices and performance criteria such as strategic
engagement, knowledge, diligence, ethics & values, oversight of the financial
reporting process, including Internal Controls and Composition of the Board and its
Committees etc.
The Nomination and Remuneration Committee and the Board found that the
performance evaluation was satisfactory and no observations were raised from the said
evaluation in the Financial Year.
Further, to comply with Regulation 25(4) of SEBI (LODR) Regulations,
Independent Directors also evaluated the performance of Non-Independent Directors,
Chairman and Board as a whole at a separate meeting of Independent Directors.
Remuneration Policy:
To comply with the provisions of Section 178 of the Act and Rules made
thereunder and Regulation 19 of SEBI Listing Regulations, the Company's Remuneration
Policy for Directors, Key Managerial Personnel (KMP), Senior Management and other
Employees of the Company is uploaded on website of the Company at https:// www.dhanuka.com/policies . The Policy includes,
interalia, the criteria for determining qualifications, positive attributes, independence
of a Director, appointment and remuneration of Directors, KMPs, Senior Management
Personnel and other employees of the Company.
Directors' Responsibility Statement
Pursuant to the provisions of Section 134(3)(c) and 134(5) of the Act
the Directors, to the best of their knowledge and ability, confirm that for the year ended
March 31, 2026:
0 in the preparation of the financial statements, the applicable
accounting standards have been followed and that there are no material departures;
0 they have selected such accounting policies and applied them
consistently and made judgements and estimates that are reasonable and prudent, so as to
give a true and fair view of the state of affairs of the Company at the end of the
Financial Year viz., March 31, 2026 and
of the profit of the Company for that period;
0 they have taken proper and sufficient care for the maintenance of
adequate accounting records in accordance with the provisions of the Act for safeguarding
the assets of the Company and for preventing and detecting fraud and other irregularities;
0 they have prepared the financial statements on a going concern basis;
0 they have laid down internal financial controls to be followed by the
Company and that such internal financial controls are adequate and are operating
effectively;
0 and they have devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems are adequate and operating
effectively.
Governance, Compliance and Ethics
Your Company maintains the highest level of transparency,
accountability and good management practices through the adoption and monitoring of
corporate strategies, goals and procedures to comply with its legal and ethical
responsibilities. The Governance, Corporate Secretarial and Legal functions of the Company
ensure maintenance of good governance within the Organisation.
The Board has also evolved and adopted a Code of Conduct as per SEBI
Listing Regulations based on the principles of good Corporate Governance and Best
Management Practices. The Code is available on the Company's website at https://www.dhanuka.com/policies
The Company has in place an automated compliance management tool for
monitoring the compliances across its corporate & registered office,plants and
offices. A compliance certificate is also placed before the Board of Directors every
quarter.
As required by SEBI Listing Regulations, a separate Report on Corporate
Governance along with the Statutory Auditors' Certificate confirming compliance with
Corporate Governance norms is annexed to this Report.
Management Discussion & Analysis
Pursuant to Regulation 34 of the SEBI Listing Regulations, the
Management Discussion & Analysis is presented in a separate section forming part of
this Annual Report. As required under the provisions of the SEBI Listing Regulations, the
Audit Committee of the Company has reviewed the Management Discussion & Analysis
report of the Company for the year ended March 31, 2026.
Business Responsibility and Sustainability Reporting
The Company is committed to addressing the needs of the communities in
which it operates, thereby maximising societal values. Additionally, it conducts its
business in a manner that generates a positive impact and enhances stakeholder value. As
per Regulation 34(2)(f) of the SEBI Listing Regulations, the Business Responsibility &
Sustainability Report depicting initiatives taken by the Company from an environmental,
social and governance perspective forms part of this Annual Report.
The said report is annexed to this Report as Annexure-"C".
Board and Committee Meetings
a. Details of Board Meetings
Five Meetings of the Board of Directors were held during the Financial
Year 2025-26. The particulars of the meetings held and attendance of each Director are
detailed in the Corporate Governance Report forming part of this Annual Report. The
maximum interval between any two meetings did not exceed 120 days, as prescribed by the
Act.
b. Details of Committees of the Board
Composition of Audit Committee
As on March 31, 2026, the Audit Committee comprised four (4) members,
of which three (3) were Independent Directors and one (1) was an Executive Director.
During the year, four (4) Audit Committee meetings were held, the details of which are
provided in the Corporate Governance Report forming part of this Annual Report.
During the year under review, Mr. Sachin Kumar Bhartiya ceased to be a
member of the Audit Committee with effect from the close of business hours on February 8,
2026, and Mr. Bajrang Lal Bajaj was inducted as a member of the Audit Committee with
effect from February 9, 2026. Further, Mr. Satish Kumar Gupta was designated as the
Chairman of the Audit Committee, and Mr. Sanjay Saxena was designated as a member of the
Audit Committee with effect from February 9, 2026.
Composition of Corporate Social Responsibility ('CSR') Committee
As on March 31, 2026, the CSR Committee comprised three (3) Members out
of which one (1) was an Independent Director and two (2) was Executive Directors. During
the year under review, one (1) CSR Committee Meeting was held, details of which are
provided in the Corporate Governance Report forming part of this Annual Report. There have
been no instances during the year when recommendations of the CSR Committee were not
accepted by the Board.
Details on other committees including their composition, number of
meetings held and terms of reference are included in the Corporate Governance Report
forming part of this Annual Report.
During the year, all recommendations made by the committees were
approved by the Board.
Corporate Social Responsibility (CSR)
Agriculture is the culture of our Country and we are nurturing the
"Culture" by protecting the same. CSR is not just a particular program but is
what your Company does every day, maximizing positive impact on society and thus helping
people to be happier. Your Company undertakes several initiatives like the implementation
of various education and training programs, the construction of schools, creating
awareness among the masses about Water Conservation and Rainwater Harvesting. These are
steps aimed at nurturing Agriculture and rural prosperity.
The Corporate Social Responsibility Policy has been is available on the
website of the Company at https://www.dhanuka.com/policies
The detailed Annual Report on the Company's CSR activities pursuant to
the Company's (Corporate Social Responsibility Policy) Rules, 2021 is given in Annexure
"D" forming part of this Report.
Policy on Prevention, Prohibition and Redressal of Sexual Harassment at
Workplace
Your Company has zero tolerance for Sexual Harassment of Women at the
Workplace in accordance with the provisions of the Sexual Harassment of Women at Workplace
(Prevention, Prohibition & Redressal) Act, 2013 and Rules made thereunder. Your
Company has constituted an Internal Complaints Committee (ICC), to inquire into the
complaints of Sexual Harassment and to recommend appropriate action. The Company firmly
believes in providing a safe, supportive, and friendly workplace environment, where our
values come to life through supporting behaviours. A positive workplace environment and a
great employee experience are an integral part of our culture. The details of complaints
during the year are provided below:
Details of complaints
| Number of complaints of sexual harassment received in the
year |
Nil |
| Number of complaints disposed off during the year |
Nil |
| Number of cases pending for more than ninety days |
Nil |
The policy on the said act is available on the Company's website at https://www.dhanuka.com/policies
Vigil Mechanism and Whistle Blower Policy
In compliance with the Section 177 of the Companies Act, 2013 and SEBI
Listing Regulations, the Whistle Blower Policy has been implemented as a mechanism for
employees to report concerns about unethical behavior or actual or suspected fraud of all
kinds, including alleged fraud by or against the Company, abuse of authority, whether made
by a named complainant or anonymously.
During the year under review the Company conducted an awareness session
on the whistleblower mechanism, which included circulation of a detailed whistle blower
template, communication to employees and external stakeholders, and display of posters
across offices, factories and group head office.
All cases reported under the Whistleblower Policy are presented to and
reviewed by the Audit Committee.
Details of the Vigil Mechanism and Whistleblower Policy are made
available on the Company's website at https://www.dhanuka.com/policies
Risk Management
The Company has established a comprehensive Risk Management Framework
designed to mitigate potential adverse impacts on business objectives while enabling the
identification and capitalisation of opportunities. In alignment with the SEBI Listing
Regulations, the Company has Risk Identification, Assessment and Mitigation Plan supported
by a Board-approved Risk Management Policy, which is periodically reviewed and updated.
The said policy is available on Company's website at https://www.dhanuka.com/policies .
The Policy provides for the systematic identification, assessment and
monitoring of risks through the creation and maintenance of a risk register, along with
the development of appropriate mitigation strategies. Key risks identified by business
units and functional teams are addressed through ongoing mitigation actions.
The Risk Management Committee, chaired by Mr. Rahul Dhanuka, Managing
Director, oversees the risk management process, monitors the status of key risks and
mitigation plans, and provides guidance on the identification of new and emergent risks.
The Board is periodically apprised of significant actual or emerging risks that could
potentially impact the Company's long-term strategy and objectives and at present there
are no risk which may threaten the existence of the Company.
Internal Financial Controls
The Audit Committee defines the scope and area of Internal Audit and
periodically reviews the Internal Audit Plans and Internal Audit Reports. Based on
Internal Audit Reports and
observations, appropriate corrective actions are suggested by the Audit
Committee. During the Financial Year, Internal Audit was regularly carried out and no
material weakness was observed. There are adequate Internal Financial controls with
reference to the financial systems. Those are periodically reviewed by the Statutory
Auditors and by the Management, Board and Committees thereof. These internal financial
controls help to put in place checks on the implementation of the internal financial
controls, policies and procedures that are adopted by the Company for ensuring an orderly
and efficient conduct of its business. These internal financial controls help in
safeguarding assets, prevention and detection of frauds and/or errors, maintaining the
accuracy and completeness of the accounting records.
Auditors
1. Statutory Auditors
M/s. S.S. Kothari Mehta & Co. LLP, Chartered Accountants (FRN -
000756N) was appointed as the statutory auditors of the Company, to hold office for the
second term of five consecutive years from the conclusion of the 38th AGM till
the conclusion of the 43rd AGM of the Company, as required under Section 139 of
the Act read with the Companies (Audit and Auditors) Rules, 2014. The Auditors have
confirmed that they are not disqualified from continuing as the Auditors of the Company.
The Audit Report of the Statutory Auditors on the Financial Statements
of the Company for FY 2025-26 forms part of this Annual Report. The Report does not
contain any qualification, reservation, adverse remark, or disclaimer which require any
explanation or comments by Board.
2. Secretarial Auditors
In terms of Section 204 of the Act and the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, M/s. Ranjeet Pandey & Associates,
Company Secretaries has been appointed as the Secretarial Auditors of the Company by the
Members of the Company at their 40th AGM of the Company held on August 1, 2025, in
accordance with the provisions of the Act and SEBI Listing Regulations to conduct
Secretarial Audit and issue the Secretarial Audit Report for a term of five (5)
consecutive years from Financial Year commencing from April 1, 2025 to March 31, 2030.
The Report of the Secretarial Auditors for FY 2025-26 is enclosed as
Annexure F which forms part of this Report. There has been no qualification, reservation,
adverse remark or disclaimer given by the Secretarial Auditors in their Report.
3. Cost Auditors
The Company is required to maintain cost records as specified by the
Central Government as per Section 148(1) of the Act and the rules framed thereunder, and
accordingly, the Company has maintained such cost accounts and records.
In terms of Section 148 of the Act read with the Companies (Cost
Records and Audit) Rules, 2014, based on the recommendations of the Audit Committee, the
Board of Directors appointed M/s. N Khandelwal & Co, Cost Accountants., being eligible
to conduct Cost Audit relating to the business of the Company for the year ending March
31, 2027.
M/s. N Khandelwal & Co. have confirmed that they are free from
disqualification specified under Section 141(3) and proviso to Section 148(3) read with
Section 141(4) of the Act and that their appointment meets the requirements of Section
141(3)(g) of the Act. They have further confirmed their independence status and that they
maintain an arm's length relationship with the Company. The remuneration payable to the
Cost Auditors is required to be placed before the Members in the General Meeting for their
ratification. Accordingly, a resolution for seeking Members' ratification for the
remuneration payable to M/s. N Khandelwal & Co. is included in the Notice of the 41st
AGM forming part of this Annual Report.
Reporting of Frauds by Auditors
During the year under review, the Statutory Auditors, Cost Auditors,
and Secretarial Auditors have not reported any instances of frauds committed in the
Company by its officers or employees, to the Audit Committee / Central Government under
Section 143(12) of the Act, details of which are required to be mentioned in this Report.
Web address for Annual Return
Pursuant to Section 92(3) of the Act and Rule 12 of the Companies
(Management and Administration) Rules, 2014 read with Section 134(3)(a) of the Act, the
Annual Return in Form MGT-7 for the Financial Year ended March 31, 2026 is available on
the Company's website at https://www.dhanuka.com/annualreturns .
Status of Listing Fees
Listing Fees for the Financial Year 2026-27 have been duly paid to BSE
and NSE, where the Company's shares are listed.
Secretarial Standards
The Company has followed the applicable Secretarial Standards with
respect to Meetings of the Board of Directors (SS-1) and General Meetings (SS-2) issued by
the Institute of Company Secretaries of India.
Measures for Conservation of Energy, Technology Absorption and details
of Foreign Exchange Earnings and Outgo
Information as required u/s 134(3)(m) of the Act read with Rule 8(3) of
the Companies (Accounts) Rules, 2014 pertaining to measures for Conservation of Energy,
Technology Absorption and details of Foreign Exchange Earning and Outgo forming part of
this Report are given in Annexure "B" of this report.
Particulars of Employees and Remuneration
The Statement of Disclosure of Remuneration under Section 197(12) of
the Act, and Rule 5 of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 ("Rules"), is appended as Annexure "H" to this
Report. The information as per Rule 5(2) and (3) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014, is provided in a separate Annexure
forming part of this Report. However, as per the first proviso to Section 136(1) of the
Act and the second proviso to Rule 5(2) of the Rules, the Report and Financial Statements
are being sent to the Members of the Company excluding the aforesaid Annexure. The said
statement will be open for Inspection upon request by the Members and any Member
interested in obtaining a copy of the said statement may write to the Company Secretary at
investors@dhanuka.com
Maternity Benefit Act, 1961
The Company is in compliance of the applicable provisions of the
Maternity Benefit Act, 1961 and the rules made thereunder, including all applicable
obligations relating to maternity benefits for eligible employees.
Other disclosures:
Your Directors state that no disclosure or reporting is required in
respect of the following matters as there were no transactions on these matters during the
year under review:
0 No significant material orders have been passed by the Regulators or
Courts or Tribunals which would impact the going concern status of the Company and its
future operations.
0 No applications were made or any proceedings were pending against the
Company under the Insolvency and Bankruptcy Code, 2016.
0 No deposits have been accepted from the public during the year under
review, and no amount on account of principal or interest on deposits from the public was
outstanding as on March 31, 2026.
0 There has been no change in the nature of business of the Company as
on the date of this Report.
0 No instance of one time settlement with any Bank or Financial
Institution.
0 Neither the Managing Director nor the Whole-time Directors of the
Company receive any salary or commission from any of the subsidiaries of the Company, as
the Company doesnot have any subsidiary as on 31st March, 2026.
0 There were no sweat equity shares and/ or issue of equity shares with
differential rights as to dividend, voting or otherwise.
Acknowledgement:
The Board places on record its deep sense of appreciation for the
committed services by all the employees of the Company. The Board would also like to
express its sincere appreciation for the assistance and co-operation received from the
Central Insecticides Board, Directorates of Agriculture, Gujarat, J&K, Rajasthan,
other Government Agencies, Bankers, Shareholders, Dealers, Distributors, Vendors, U.S.,
European & Japanese MNCs and the Farming Community who have reposed their trust and
confidence in the Company.